| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 4,212,000 | 3,665,000 | 3,091,000 | | Cost of Revenue | 2,127,000 | 1,805,000 | 1,212,000 | | | Gross Profit | 2,085,000 | 1,860,000 | 1,879,000 | | | Operating Expenses | | Research Development | 1,359,000 | 1,145,000 | 1,041,000 | | Selling General and Administrative | 1,023,000 | 927,000 | 754,000 | | Non Recurring | 472,000 | 241,000 | 18,000 | | Others | 58,000 | 34,000 | 27,000 | | | | Total Operating Expenses | 2,912,000 | 2,347,000 | 1,840,000 | | | | Operating Income or Loss | (827,000) | (487,000) | 39,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (28,000) | (20,000) | 99,000 | | Earnings Before Interest And Taxes | (855,000) | (507,000) | 138,000 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (855,000) | (507,000) | 138,000 | | Income Tax Expense | 233,000 | (53,000) | 66,000 | | Minority Interest |
-
|
-
| 4,000 | | | | Net Income From Continuing Ops | (1,088,000) | (454,000) | 76,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,088,000) | (454,000) | 76,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,088,000) | ($454,000) | $76,000 |
|
1.48% Nasdaq 
Income Statement
